296 related articles for article (PubMed ID: 9738515)
1. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
2. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
[TBL] [Abstract][Full Text] [Related]
3. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
4. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
[TBL] [Abstract][Full Text] [Related]
5. Endocrine and physical determinants of bone mass in late postmenopause.
Albanese CV; Civitelli R; Tibollo FG; Masciangelo R; Mango D
Exp Clin Endocrinol Diabetes; 1996; 104(3):263-70. PubMed ID: 8817245
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
Dawson-Hughes B; Dallal GE; Krall EA; Sadowski L; Sahyoun N; Tannenbaum S
N Engl J Med; 1990 Sep; 323(13):878-83. PubMed ID: 2203964
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
8. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.
Gertz BJ; Shao P; Hanson DA; Quan H; Harris ST; Genant HK; Chesnut CH; Eyre DR
J Bone Miner Res; 1994 Feb; 9(2):135-42. PubMed ID: 8140926
[TBL] [Abstract][Full Text] [Related]
9. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
[TBL] [Abstract][Full Text] [Related]
10. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.
Devogelaer JP; Broll H; Correa-Rotter R; Cumming DC; De Deuxchaisnes CN; Geusens P; Hosking D; Jaeger P; Kaufman JM; Leite M; Leon J; Liberman U; Menkes CJ; Meunier PJ; Reid I; Rodriguez J; Romanowicz A; Seeman E; Vermeulen A; Hirsch LJ; Lombardi A; Plezia K; Santora AC; Yates AJ; Yuan W
Bone; 1996 Feb; 18(2):141-50. PubMed ID: 8833208
[TBL] [Abstract][Full Text] [Related]
11. Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study.
Scharla SH; Scheidt-Nave C; Leidig G; Woitge H; Wüster C; Seibel MJ; Ziegler R
Exp Clin Endocrinol Diabetes; 1996; 104(3):289-92. PubMed ID: 8817249
[TBL] [Abstract][Full Text] [Related]
12. Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling.
Chesnut CH; McClung MR; Ensrud KE; Bell NH; Genant HK; Harris ST; Singer FR; Stock JL; Yood RA; Delmas PD
Am J Med; 1995 Aug; 99(2):144-52. PubMed ID: 7625419
[TBL] [Abstract][Full Text] [Related]
13. Bone turnover markers and bone density across the menopausal transition.
Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers of bone turnover in lactating and nonlactating postpartum women.
Sowers M; Eyre D; Hollis BW; Randolph JF; Shapiro B; Jannausch ML; Crutchfield M
J Clin Endocrinol Metab; 1995 Jul; 80(7):2210-6. PubMed ID: 7608281
[TBL] [Abstract][Full Text] [Related]
15. The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study.
Ravn P; Clemmesen B; Riis BJ; Christiansen C
Bone; 1996 Nov; 19(5):527-33. PubMed ID: 8922653
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
17. Calcium supplementation and increases in bone mineral density in children.
Johnston CC; Miller JZ; Slemenda CW; Reister TK; Hui S; Christian JC; Peacock M
N Engl J Med; 1992 Jul; 327(2):82-7. PubMed ID: 1603140
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
Adami S; Passeri M; Ortolani S; Broggini M; Carratelli L; Caruso I; Gandolini G; Gnessi L; Laurenzi M; Lombardi A
Bone; 1995 Oct; 17(4):383-90. PubMed ID: 8573412
[TBL] [Abstract][Full Text] [Related]
19. The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women.
Harris ST; Gertz BJ; Genant HK; Eyre DR; Survill TT; Ventura JN; DeBrock J; Ricerca E; Chesnut CH
J Clin Endocrinol Metab; 1993 Jun; 76(6):1399-406. PubMed ID: 8501142
[TBL] [Abstract][Full Text] [Related]
20. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
Struys A; Snelder AA; Mulder H
Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
